Literature DB >> 27253715

An Evolved RNA Recognition Motif That Suppresses HIV-1 Tat/TAR-Dependent Transcription.

David W Crawford, Brett D Blakeley, Po-Han Chen1, Chringma Sherpa2, Stuart F J Le Grice2, Ite A Laird-Offringa1, Brian R McNaughton.   

Abstract

Potent and selective recognition and modulation of disease-relevant RNAs remain a daunting challenge. We previously examined the utility of the U1A N-terminal RNA recognition motif as a scaffold for tailoring new RNA hairpin recognition and showed that as few as one or two mutations can result in moderate affinity (low μM dissociation constant) for the human immunodeficiency virus (HIV) trans-activation response element (TAR) RNA, an RNA hairpin controlling transcription of the human immunodeficiency virus (HIV) genome. Here, we use yeast display and saturation mutagenesis of established RNA-binding regions in U1A to identify new synthetic proteins that potently and selectively bind TAR RNA. Our best candidate has truly altered, not simply broadened, RNA-binding selectivity; it binds TAR with subnanomolar affinity (apparent dissociation constant of ∼0.5 nM) but does not appreciably bind the original U1A RNA target (U1hpII). It specifically recognizes the TAR RNA hairpin in the context of the HIV-1 5'-untranslated region, inhibits the interaction between TAR RNA and an HIV trans-activator of transcription (Tat)-derived peptide, and suppresses Tat/TAR-dependent transcription. Proteins described in this work are among the tightest TAR RNA-binding reagents-small molecule, nucleic acid, or protein-reported to date and thus have potential utility as therapeutics and basic research tools. Moreover, our findings demonstrate how a naturally occurring RNA recognition motif can be dramatically resurfaced through mutation, leading to potent and selective recognition-and modulation-of disease-relevant RNA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27253715      PMCID: PMC5199234          DOI: 10.1021/acschembio.6b00145

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  62 in total

1.  The leader of the HIV-1 RNA genome forms a compactly folded tertiary structure.

Authors:  B Berkhout; J L van Wamel
Journal:  RNA       Date:  2000-02       Impact factor: 4.942

2.  In vitro genetic analysis of RNA-binding proteins using phage display.

Authors:  I A Laird-Offringa
Journal:  Methods Mol Biol       Date:  1999

3.  Complex role of the beta 2-beta 3 loop in the interaction of U1A with U1 hairpin II RNA.

Authors:  Phinikoula S Katsamba; Melina Bayramyan; Ian S Haworth; David G Myszka; Ite A Laird-Offringa
Journal:  J Biol Chem       Date:  2002-06-24       Impact factor: 5.157

4.  CLAMP: a biosensor kinetic data analysis program.

Authors:  D G Myszka; T A Morton
Journal:  Trends Biochem Sci       Date:  1998-04       Impact factor: 13.807

5.  Deoxystreptamine dimers bind to RNA hairpin loops.

Authors:  Xianjun Liu; Jason R Thomas; Paul J Hergenrother
Journal:  J Am Chem Soc       Date:  2004-08-04       Impact factor: 15.419

6.  Small molecule ligands for bulged RNA secondary structures.

Authors:  S Todd Meyer; Paul J Hergenrother
Journal:  Org Lett       Date:  2009-09-17       Impact factor: 6.005

7.  A simple ligand that selectively targets CUG trinucleotide repeats and inhibits MBNL protein binding.

Authors:  Jonathan F Arambula; Sreenivasa Rao Ramisetty; Anne M Baranger; Steven C Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-08       Impact factor: 11.205

8.  RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1.

Authors:  J Clever; C Sassetti; T G Parslow
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

9.  RNA motif discovery by SHAPE and mutational profiling (SHAPE-MaP).

Authors:  Nathan A Siegfried; Steven Busan; Greggory M Rice; Julie A E Nelson; Kevin M Weeks
Journal:  Nat Methods       Date:  2014-07-13       Impact factor: 28.547

10.  The role of the C-terminal helix of U1A protein in the interaction with U1hpII RNA.

Authors:  Michael J Law; Diane S Lee; Charlene S Lee; Paul P Anglim; Ian S Haworth; Ite A Laird-Offringa
Journal:  Nucleic Acids Res       Date:  2013-05-22       Impact factor: 16.971

View more
  14 in total

1.  Programmable RNA-Guided RNA Effector Proteins Built from Human Parts.

Authors:  Simone Rauch; Emily He; Michael Srienc; Huiqing Zhou; Zijie Zhang; Bryan C Dickinson
Journal:  Cell       Date:  2019-06-20       Impact factor: 41.582

Review 2.  Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery.

Authors:  Sai Shashank Chavali; Rachel Bonn-Breach; Joseph E Wedekind
Journal:  J Biol Chem       Date:  2019-05-12       Impact factor: 5.157

Review 3.  The potential of engineered eukaryotic RNA-binding proteins as molecular tools and therapeutics.

Authors:  Carl R Shotwell; John D Cleary; J Andrew Berglund
Journal:  Wiley Interdiscip Rev RNA       Date:  2019-11-03       Impact factor: 9.957

Review 4.  Exosomal packaging of trans-activation response element (TAR) RNA by HIV-1 infected cells: a pro-malignancy message delivery to cancer cells.

Authors:  Nilesh Kumar Sharma
Journal:  Mol Biol Rep       Date:  2019-03-22       Impact factor: 2.316

5.  Molecular recognition of a branched peptide with HIV-1 Rev Response Element (RRE) RNA.

Authors:  Yumin Dai; Ashley N Peralta; Jessica E Wynn; Chringma Sherpa; Hao Li; Astha Verma; Stuart F J Le Grice; Webster L Santos
Journal:  Bioorg Med Chem       Date:  2019-03-07       Impact factor: 3.641

Review 6.  Methods for the directed evolution of biomolecular interactions.

Authors:  Victoria Cochran Xie; Matthew J Styles; Bryan C Dickinson
Journal:  Trends Biochem Sci       Date:  2022-05       Impact factor: 14.264

7.  Structure of HIV TAR in complex with a Lab-Evolved RRM provides insight into duplex RNA recognition and synthesis of a constrained peptide that impairs transcription.

Authors:  Ivan A Belashov; David W Crawford; Chapin E Cavender; Peng Dai; Patrick C Beardslee; David H Mathews; Bradley L Pentelute; Brian R McNaughton; Joseph E Wedekind
Journal:  Nucleic Acids Res       Date:  2018-07-27       Impact factor: 16.971

8.  Amiloride as a new RNA-binding scaffold with activity against HIV-1 TAR.

Authors:  Neeraj N Patwardhan; Laura R Ganser; Gary J Kapral; Christopher S Eubanks; Janghyun Lee; Bharathwaj Sathyamoorthy; Hashim M Al-Hashimi; Amanda E Hargrove
Journal:  Medchemcomm       Date:  2017-03-15       Impact factor: 3.597

Review 9.  Structural Fluidity of the Human Immunodeficiency Virus Rev Response Element.

Authors:  Chringma Sherpa; Stuart F J Le Grice
Journal:  Viruses       Date:  2020-01-11       Impact factor: 5.048

10.  Co-crystal structures of HIV TAR RNA bound to lab-evolved proteins show key roles for arginine relevant to the design of cyclic peptide TAR inhibitors.

Authors:  Sai Shashank Chavali; Sachitanand M Mali; Jermaine L Jenkins; Rudi Fasan; Joseph E Wedekind
Journal:  J Biol Chem       Date:  2020-10-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.